Company News

Share this article:

Sanofi-Aventis announced the acquisition of Medley, a Brazilian pharmaceutical manufacturer, for $658 million. The transaction is expected to be finalized during the second quarter of 2009. According to a Sanofi release, Medley is the third largest pharmaceutical company—and the largest generic manufacturer—in Brazil. Medley posted roughly $201 million in sales for 2008, according to the statement.

 

Takeda announced plans to expand sales and marketing operations in Spain and Ireland. In Spain, the company will commence with promotional activities in support of Blopress, a blood pressure drug, and Glustin, a diabetes treatment. In Ireland, the company expanded promotional activities for Actos, a treatment for type 2 diabetes.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.